Volume 150, Issue 2, Pages 312-314 (February 2016) Novel Transarterial Biomimetic-Based Nanoparticles for the Treatment of Hepatocellular Carcinoma Riccardo Lencioni Gastroenterology Volume 150, Issue 2, Pages 312-314 (February 2016) DOI: 10.1053/j.gastro.2015.12.022 Copyright © 2016 AGA Institute Terms and Conditions
Figure 1 Intraoperative fluorescent-navigated tissue resection in hepatocellular carcinoma (HCC). Illustration showing the potential low-density lipoprotein (LDL)–docosahexaenoic acid (DHA) nanoparticles in intraoperative fluorescent navigation imaging to treat HCC patients. Based in part on the data presented by Wen et al.6 Additionally, nanoparticles coupled with antibody complexes that specifically recognize malignant liver cells11 could result in a much higher efficacy in the removal of HCC affected tissue. FITC, fluorescein isothiocyanate. Gastroenterology 2016 150, 312-314DOI: (10.1053/j.gastro.2015.12.022) Copyright © 2016 AGA Institute Terms and Conditions